Publications by authors named "Michael W Boyer"

17Publications

Using CD19 chimeric antigen receptor-T cell therapy in a 4-month-old patient with infantile acute lymphoblastic leukemia.

Pediatr Blood Cancer 2020 04 11;67(4):e28155. Epub 2020 Jan 11.

Division of Pediatric Hematology/Oncology, University of Utah School of Medicine, Salt Lake City, Utah.

View Article and Find Full Text PDF
April 2020

Tisagenlecleucel Model-Based Cellular Kinetic Analysis of Chimeric Antigen Receptor-T Cells.

CPT Pharmacometrics Syst Pharmacol 2019 05 7;8(5):285-295. Epub 2019 Mar 7.

Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

View Article and Find Full Text PDF
May 2019

Chimeric antigen receptor T-cell therapy hits the market.

Authors:
Michael W Boyer

Immunotherapy 2018 08;10(11):911-912

Associate Professor of Pediatrics & Internal Medicine, University of Utah, Division of Pediatric Hematology/Oncology/BMT, 100 N Mario Capecchi Dr, Salt Lake City, UT 84132, USA.

View Article and Find Full Text PDF
August 2018

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation.

J Clin Oncol 2017 Dec 17;35(36):4003-4011. Epub 2017 Oct 17.

Robert J. Soiffer, Haesook T. Kim, Vincent T. Ho, Edwin P. Alyea, and Jerome Ritz, Dana-Farber Cancer Institute; James D. Levine, Beth Israel Deaconess Medical Center and Harvard Medical School; Yi-Bin Chen, Massachusetts General Hospital, Boston; Frank Glavin, Neovii Biotech, Lexington, MA; Joseph McGuirk, University of Kansas Medical Center, Kansas City, KS; Mitchell E. Horwitz, Duke University Medical Center, Durham; Thomas C. Shea, University of North Carolina School of Medicine, Chapel Hill, NC; Laura Johnston, Stanford University, Stanford, CA; Mrinal M. Patnaik, Mayo Clinic, Rochester, MN; Witold Rybka, Penn State College of Medicine, Hershey; David L. Porter, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA; Andrew Artz, University of Chicago, Chicago; Patrick J. Stiff, Loyola University Medical Center, Maywood, IL; Michael W. Boyer, University of Utah, Salt Lake City, UT; Richard T. Maziarz, Oregon Health & Science University, Portland, OR; Paul J. Shaughnessy, Texas Transplant Institute, San Antonio; Madhuri Vusirikala, University of Texas Southwestern Medical Center, Dallas, TX; Usama Gergis, Weill Cornell Medical College; Ran Reshef, Columbia University Medical Center, New York, NY; Hana Safah, Tulane University, New Orleans, LA; John F. DiPersio and Peter Westervelt, Washington University School of Medicine, St Louis, MO; Jeff Szer, Royal Melbourne Hospital, Parkville, Victoria; Ian D. Lewis, Royal Adelaide Hospital, Adelaide, South Australia, Australia; Jennifer Holter, University of Oklahoma Health Sciences Center, Oklahoma City, OK; Paul J. Martin, Fred Hutchinson Cancer Research Center, Seattle, WA; Joseph A. Pidala, H. Lee Moffitt Cancer Center, Tampa, FL; and Madan H. Jagasia, Vanderbilt University Medical Center, Nashville, TN.

View Article and Find Full Text PDF
December 2017

Survivin and Granzyme B-induced apoptosis, a novel anticancer therapy.

Mol Cancer Ther 2006 Mar;5(3):693-703

Center for Childhood Cancer, Columbus Children's Research Institute, Room WA5021, 700 Children's Drive, Columbus, OH 43205, USA.

View Article and Find Full Text PDF
March 2006

Low risk of graft-versus-host disease with transplantation of CD34 selected peripheral blood progenitor cells from alternative donors for Fanconi anemia.

J Pediatr Hematol Oncol 2003 Nov;25(11):890-5

Section of Blood and Marrow Transplantation, Division of Hematology/Oncology, Cincinnati Children's Hospital Medical Center, USA.

View Article and Find Full Text PDF
November 2003

Ex vivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cells while preserving graft-versus-leukemia effects.

Biol Blood Marrow Transplant 2003 Oct;9(10):616-32

Hematology/Oncology Department, Winship Cancer Institute, Emory University, 1639 Pierce Drive, Atlanta, GA 30322, USA.

View Article and Find Full Text PDF
October 2003